普米克令舒联合博利康尼氧气雾化吸入治疗毛细支气管炎120例被引量：1

Pulmicort combined Bricanyl inhalation of oxygen in treatment of bronchiolitis 120 cases

导出

摘要目的观察普米克联合博利康尼以氧气作动力雾化吸入治疗毛细支气管炎的疗效。方法将240例毛细支气管炎患儿随机分为两组,观察组120例在常规治疗的基础上辅以普米克令舒联合博利康尼氧驱雾化吸入;对照组120例仅进行常规治疗。结果观察组咳喘消失时间、肺部湿啰音消失时间和住院时间均优于对照组(P<0.05),观察组总有效率91.7%,对照组总有效率55%,两组疗效差异有统计学意义(P<0.05)。结论普米克令舒联合博利康尼治疗小儿毛细支气管炎的临床疗效确切,值得临床推广使用。 Objective To observe the effect of Pulmicort combined Bricanyl with oxygen inhalation therapy for bronchiolitis.Methods Totally 240 patients with bronchiolitis were randomly divided into two groups,120 patients in the observation group on the basis of conventional therapy supplemented by joint Bricanyl Pulmicort inhalation of oxygen flooding;Control group,only routine treatment of 120 cases.Results The study group cough lost time,pulmonary auscultation and hospital stay were betler than that of the control group（P0.05） ,observation group the total effective rate was 91.7%,that of the control group the total efficiency 55%,the difference between the two groups efficacy was statistically significant（P0.05） .Conclusions The combined Pulmicort and Bricanyl clinical treatment of children with bronchiolitis is effective,is worthy of clinical use.

作者闫伯强

机构地区三门峡市中心医院呼吸内科

出处《医药论坛杂志》 2011年第10期107-108,110,共3页 Journal of Medical Forum

关键词普米克令舒博利康尼毛细支气管炎雾化吸入 Pulmicort Bricanyl Bronchiolitis Inhalation

分类号 R562.21 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献5

1胡亚美,诸福堂.实用儿科学[M].7版.北京:人民卫生出版社,2002:1174
2Psarras S, Papadopoulos NG, Johnston SL. Pathogenesis of respiratory syncytial virus bronchiolitis -related wheezing [ J ]. Paedimr Respir Rev, 2004, 5SupplA: S179-184.
3师廷明.氧气驱动雾化吸入普米克令舒及博利康尼治疗毛细支气管炎42例疗效观察[J].基层医学论坛,2006,10(2):135-136. 被引量：10
4陈福将（综述）,李昌崇（审校）.毛细支气管炎的药物治疗研究进展[J].国际儿科学杂志,2007,34(2):101-103. 被引量：38
5江月明,廖志勤.毛细支气管炎发生哮喘的影响因素分析[J].广东医学院学报,2005,23(5):546-547. 被引量：9

二级参考文献22

1中华人民共和国卫生部.小儿四病防治方案（二），小儿肺炎防治方案[J].中华儿科杂志,1987,25(1):47-47.
2Spahn JD,Szefler SJ. Childhood asthma: New insights into management[J]. J Allergy Clin Immunol,2002,109(1):3-13.
3Sigurs N, Bjarnason R,Sigurbergsson F, et al. Respiratory syncytial vires bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7[J]. Am J Respir Crit Care Med,2000,161(5) : 1501-1507.
4Everard ML, Swarbfick A, Rigby AS, et al. The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity[J]. Respir Med,2001,95(4) :275-280.
5Edell D, Khoshoo V, Ross G, et al. Early ribavafin treatment of bronchiolitis effect on ling-term respiratory morbidity[J] .Chest,2002,122(3) :935-939.
6American Academy of Pediatrics,Committee on Infectious Diseases.Respiratory syncytial virus.Red book:2003 report of the Committee on Infectious Diseases[R].26th ed. EIK Grove village,1V:American Academy of Pediatrics,2003:523-528.
7Patel H,Platt RW,Pekeles GS,et al.A randomized,controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis[J] .J Pediatr,2002,141 (6) :818-824.
8Totapally BR, Demerci C, Zareikat G, et al. Tidal breathing flow-volume loops in bronchiolitis in infancy: the effect of albuterol[J]. Crit Care,2022,6(2) : 160-165.
9Wainwright C, Altamirano L, Cheney M, et al. A muilticenter, randomized,double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis[ J ]. N Engl J Med, 2003,349( 1 ) : 27-35.
10King V J, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review[J]. Arch Pediatr Adolesc Med,2004,158(2) : 127-137.